CLINICAL AND LABORATORY MARKERS OF ASTHENIC SYNDROME IN PATIENTS WITH SARCOIDOSIS

Download full text PDF
Issue: 
7
Year: 
2016

Professor B. Volel (1), MD; E. Makukh (1); M. Lebedeva (1), Candidate of Medical Sciences; Professor E. Popova (1), MD; V. Sholomova (1); L. Androsova (2), Candidate of Medical Sciences; Professor N. Mukhin (1), MD, Academician of the Russian Academy of Sciences; V. Beketov (3), M. Brovko (1), Professor T. Klyushnik (2), MD 1 -I.M. Sechenov First Moscow State Medical University 2 -Mental Health Research Center, Russian Academy of Sciences, Moscow 3 -M.V. Lomonosov Moscow State University

Psychosomatic and immunological changes were analyzed in patients with sarcoidosis-associated asthenia. There was an association of hypostenic asthenia with slowly progressive sarcoidosis.
Keywords: 
pulmonology
sarcoidosis
asthenic syndrome
leukocyte elastase
anti-neuroantigen autoantibodies

It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

References: 
  1. Popova E.N., Parfenov V.A. Sarkoidoz legkih hronicheskogo techenija s porazheniem nervnoj sistemy i serdtsa // Nevrologija, nejropsihiatrija, psihosomatika. – 2009; 1: 47–50.
  2. Chuchalin A.G. (red.). Sarkoidoz: uchebno-metodicheskoe posobie dlja sl shatelej poslevuzovskogo i dopolnitel'nogo professional'nogo obrazova-nija / Kazan', 2010; s. 58.
  3. Baughman R., Grutters J. New treatment strategies for pulmonary sarcoidosis: 3. antimetabolites, biological drugs, and other treatment approaches // Lancet. – 2015; 3 (10): 813–22.
  4. Jaswa A., Kasper L., Bak V. et al. Differential Inflammatory MicroRNA and 4. Cytokine Expression in Pulmonary Sarcoidosis // Arch. Immunol. Ther. Exp. – 2015; 63: 139–46.
  5. Drent M., Lower E., De Vries J. Sarcoidosis-associated fatigue // Eur. Respir. 5. J. – 2012; 40: 255–63.
  6. Kljushnik T.P., Sergienko N.S., Danilovskaja E.V. i dr. Autoantitela k 6. faktoru rosta nervov pri narushenijah psihicheskogo razvitija detej rannego vozrasta // Zhurn. nevrol. i psihiat. – 1999; 99 (6): 44–6.
  7. Jarovaja G.A. Svojstva i kliniko-diagnosticheskoe znachenie opredelenija 7. elastazy iz pankreaticheskoj zhelezy i polimorfnojadernyh lejkotsitov // Laboratornaja meditsina. – 2006; 8: 11–8.
  8. American Thoracic Society. Statement on sarcoidosis // Am. J. Respir. Crit. 8. Care Med. – 1999; 160: 736–55.
  9. Dotsenko V.L., Neshkova E.A., Jarovaja G.A. Vyjavlenie lejkotsitarnoj 9. elastazy cheloveka iz kompleksa s plazmennym α1-proteinaznym ingibito-rom po ee enzimaticheskoj aktivnosti s sinteticheskim substratom // Vopr. med. himii. – 1994; 40 (3): 20–5.
  10. Nartikova V.F., Pashina T.S. Unifitsirovannyj metod opredele-10. nija aktivnosti α1-antitripsina i α2-makroglobulina aktivnosti v syvorotke krovi cheloveka (plazmy) // Vopr. med. himii. – 1979; 25 (4): 494–9.
  11. Androsova L.V., Mihajlova N.M., Zozulja S.A. i dr. Markery vospale-11. nija pri shizofrenii pozdnego vozrasta // Zhurn. nevrol. i psihiat. im. S.S. Korsakova. – 2014; 114 (12): 60–4.
  12. Rozy A., Czerniawska J., Stepniewska A. Inflammatory markers in the 12. exhaled breath condensate of patients with pulmonary sarcoidosis // J. Physiol. Pharmacol. – 2006; 57 (4): 335–40.